Premalignant and Malignant Perianal Lesions

Abstract

Anal cancer is a heterogeneous and rare disease process that accounts for ∼1.5% of all gastrointestinal tract malignancies. The perianal skin plays host to a variety of different premalignant and malignant lesions, all with variable histology, treatment options, and prognosis. Anal cancers in general are notorious for having a delayed or missed diagnosis leading to treatment delays and may have an impact on survival. This delay is in part due to the nonspecific symptomatology and also improper physical examination of the sensitive and anatomically complex perianal region and anal canal. This article examines the various types of perianal cancers and their precursor lesions and will explore treatment options as well as outcomes and prognosis.

Keywords

perianal cancers - squamous cell carcinoma - basal cell carcinoma - extramammary Paget's disease - anal adenocarcinoma - Buschke–Löwenstein tumor - verrucous carcinoma - mycosis fungoides

• References

• 1 Welton ML, Steele SR, Goodman KA. , et al. Anus. In: Amin MB. (Editor-in-chief), AJCC Cancer Staging Manual. 8th edition. New York, NY: Springer; 2017: 275-284
• 2 Steele SR, Varma MG, Melton GB, Ross HM, Rafferty JF, Buie WD. ; Standards Practice Task Force of the American Society of Colon and Rectal Surgeons. Practice parameters for anal squamous neoplasms. Dis Colon Rectum 2012; 55 (07) 735-749
• 3 Nigro ND, Vaitkevicius VK, Buroker T, Bradley GT, Considine B. Combined therapy for cancer of the anal canal. Dis Colon Rectum 1981; 24 (02) 73-75
• 4 Young SC, Solomon MJ, Hruby G, Frizelle FA. Review of 120 anal cancer patients. Colorectal Dis 2009; 11 (09) 909-914
• 5 Glynne-Jones R, Meadows H, Wan S. , et al; National Cancer Research Institute Anal Sub Group and Colorectal Clinical Oncology Group. EXTRA--a multicenter phase II study of chemoradiation using a 5 day per week oral regimen of capecitabine and intravenous mitomycin C in anal cancer. Int J Radiat Oncol Biol Phys 2008; 72 (01) 119-126
• 6 Pepek JM, Willett CG, Wu QJ, Yoo S, Clough RW, Czito BG. Intensity-modulated radiation therapy for anal malignancies: a preliminary toxicity and disease outcomes analysis. Int J Radiat Oncol Biol Phys 2010; 78 (05) 1413-1419
• 7 Mullen JT, Rodriguez-Bigas MA, Chang GJ. , et al. Results of surgical salvage after failed chemoradiation therapy for epidermoid carcinoma of the anal canal. Ann Surg Oncol 2007; 14 (02) 478-483
• 8 Welton ML, Sharkey FE, Kahlenberg MS. The etiology and epidemiology of anal cancer. Surg Oncol Clin N Am 2004; 13 (02) 263-275
• 9 Trombetta LJ, Place RJ. Giant condyloma acuminatum of the anorectum: trends in epidemiology and management: report of a case and review of the literature. Dis Colon Rectum 2001; 44 (12) 1878-1886
• 10 Zidar N, Langner C, Odar K. , et al. Anal verrucous carcinoma is not related to infection with human papillomaviruses and should be distinguished from giant condyloma (Buschke-Löwenstein tumour). Histopathology 2017; 70 (06) 938-945
• 11 Patel KR, Chernock RD, Zhang TR, Wang X, El-Mofty SK, Lewis Jr JS. Verrucous carcinomas of the head and neck, including those with associated squamous cell carcinoma, lack transcriptionally active high-risk human papillomavirus. Hum Pathol 2013; 44 (11) 2385-2392
• 12 Paterson CA, Young-Fadok TM, Dozois RR. Basal cell carcinoma of the perianal region: 20-year experience. Dis Colon Rectum 1999; 42 (09) 1200-1202
• 13 Nielsen OV, Jensen SL. Basal cell carcinoma of the anus-a clinical study of 34 cases. Br J Surg 1981; 68 (12) 856-857
• 14 Gordon PH. Current status--perianal and anal canal neoplasms. Dis Colon Rectum 1990; 33 (09) 799-808
• 15 Skibber J, Rodriguez-Bigas MA, Gordon PH. Surgical considerations in anal cancer. Surg Oncol Clin N Am 2004; 13 (02) 321-338
• 16 National Comprehensive Cancer Network. Anal carcinoma (Version 2. 2017 http://www.nccn.org/professionals/physician_gls/pdf/anal.pdf . Accessed November 6, 2017
• 17 Row D, Weiser MR. Anorectal melanoma. Clin Colon Rectal Surg 2009; 22 (02) 120-126
• 18 Tariq MU, Ud Din N, Ud Din NF, Fatima S, Ahmad Z. Malignant melanoma of anorectal region: a clinicopathologic study of 61 cases. Ann Diagn Pathol 2014; 18 (05) 275-281
• 19 Zhang S, Gao F, Wan D. Effect of misdiagnosis on the prognosis of anorectal malignant melanoma. J Cancer Res Clin Oncol 2010; 136 (09) 1401-1405
• 20 Falch C, Stojadinovic A, Hann-von-Weyhern C. , et al. Anorectal malignant melanoma: extensive 45-year review and proposal for a novel staging classification. J Am Coll Surg 2013; 217 (02) 324-335
• 21 Bello DM, Smyth E, Perez D. , et al. Anal versus rectal melanoma: does site of origin predict outcome?. Dis Colon Rectum 2013; 56 (02) 150-157
• 22 Kiran RP, Rottoli M, Pokala N, Fazio VW. Long-term outcomes after local excision and radical surgery for anal melanoma: data from a population database. Dis Colon Rectum 2010; 53 (04) 402-408
• 23 Ishizone S, Koide N, Karasawa F. , et al. Surgical treatment for anorectal malignant melanoma: report of five cases and review of 79 Japanese cases. Int J Colorectal Dis 2008; 23 (12) 1257-1262
• 24 Yeh JJ, Shia J, Hwu WJ. , et al. The role of abdominoperineal resection as surgical therapy for anorectal melanoma. Ann Surg 2006; 244 (06) 1012-1017
• 25 Chang AE, Karnell LH, Menck HR. ; The American College of Surgeons Commission on Cancer and the American Cancer Society. The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. Cancer 1998; 83 (08) 1664-1678
• 26 Beck DE, Fazio VW. Perianal Paget's disease. Dis Colon Rectum 1987; 30 (04) 263-266
• 27 Garrett K, Kalady MF. Anal neoplasms. Surg Clin North Am 2010; 90 (01) 147-161
• 28 Tulchinsky H, Zmora O, Brazowski E, Goldman G, Rabau M. Extramammary Paget's disease of the perianal region. Colorectal Dis 2004; 6 (03) 206-209
• 29 Armitage NC, Jass JR, Richman PI, Thomson JP, Phillips RK. Paget's disease of the anus: a clinicopathological study. Br J Surg 1989; 76 (01) 60-63
• 30 Isik O, Aytac E, Brainard J, Valente MA, Abbas MA, Gorgun E. Perianal Paget's disease: three decades experience of a single institution. Int J Colorectal Dis 2016; 31 (01) 29-34
• 31 McCarter MD, Quan SHQ, Busam K, Paty PP, Wong D, Guillem JG. Long-term outcome of perianal Paget's disease. Dis Colon Rectum 2003; 46 (05) 612-616
• 32 Moore HG, Guillem JG. Anal neoplasms. Surg Clin North Am 2002; 82 (06) 1233-1251
• 33 Chang GJ, Gonzalez RJ, Skibber JM, Eng C, Das P, Rodriguez-Bigas MA. A twenty-year experience with adenocarcinoma of the anal canal. Dis Colon Rectum 2009; 52 (08) 1375-1380
• 34 Jensen SL, Shokouh-Amiri MH, Hagen K, Harling H, Nielsen OV. Adenocarcinoma of the anal ducts. A series of 21 cases. Dis Colon Rectum 1988; 31 (04) 268-272
• 35 Jawed SI, Myskowski PL, Horwitz S, Moskowitz A, Querfeld C. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome). J Am Acad Dermatol 2014; 70 (02) 205.e1-e16
• 36 Weinstock MA, Reynes JF. The changing survival of patients with mycosis fungoides: a population-based assessment of trends in the United States. Cancer 1999; 85 (01) 208-212